3MF-28487-06164
1 vaccination
1 coded response
8 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 439 / OH
- Registered
- 2021-11-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-28
Dose 1 — Pfizer-BioNTechCo-administered: Flu
-
2021-11-29
Registered in v-safe
-
2021-11-29
Survey response — days 1–6 daily, dose 1MedDRA: Dyspnoea, Palpitations — Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tirednessFree text: Shortness of breath and racing heartMedDRA releases: 2024-11 · check-in free text available
- 2021-11-30
-
2021-12-01
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-12-02
- 2021-12-03
- 2021-12-04
- 2021-12-05
- 2021-12-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-28 | Pfizer-BioNTech | Flu |
Free text
Release 10 — days 1–6 daily, dose 1
Systemic reaction (other): Shortness of breath and racing heart
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dyspnoea | · | · | ✓ |
| SRO | Palpitations | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release